JPRN-UMIN000006674
Completed
Phase 2
A Phase II study of neoadjuvant combination chemotherapy with TS-1, cisplatin and Paclitaxel (PCS) for resectable advanced gastric cancer. - NECESSIT study
Kinki University Faculty of Medicine0 sites20 target enrollmentNovember 8, 2011
Conditionsresectable advanced gastric cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- resectable advanced gastric cancer
- Sponsor
- Kinki University Faculty of Medicine
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) With severe allergy to TS\-1, Cisplatin and Paclitaxel 2\) Women who are pregnant or breastfeeding. 3\) Men who are unwilling to avoid pregnancy. 4\) Active infection and inflammation. 5\) History of cardiac disease 6\) Dyspnea at rest
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Phase Ib/II study assessing the neo-adjuvant combination therapy of vinflunine with cisplatin followed by radical cystectomy in patients with muscle-invasive bladder cancerEUCTR2016-000081-33-DEigartis GmbH42
Recruiting
Phase 2
PhaseII Study of Neoadjuvant and adjuvant Chemotherapy with Pemetrexed/Carboplatin/Bevacizumab in patients with non-squamouns non Small-cell lung canceron-Squamouns Non-small-cell-lung-cancerJPRN-UMIN000009032Kansai Medical University Hirakata Hospital35
Completed
Phase 2
A Phase II Study of Neo-adjuvant Combination Therapy of Trastuzumab and Anastrozole for Hormone Receptor-Positive, HER2-Positive Postmenopausal Breast Cancer(WJOG7412B)Hormone receptor-positive, HER2-positive postmenopausal breast cancerJPRN-UMIN000011023West Japan Oncology Group70
Completed
Phase 2
Phase II trial of neoadjuvant combination chemotherapy with gemcitabine and S-1 for locally advanced pancreatic cancerlocally advanced pancreatic cancerJPRN-UMIN000001450Faculty of Medicine, Kyoto University35
Completed
Phase 2
A phase II trial of Neoadjuvant and adjuvant chemotherapy with Gemcitabine and TS-1 combination for patients with locally advanced pancreatic cancerpancreatic cancerJPRN-UMIN000005578Chiba study group of adjuvant chemotherapy for pancreatic cancer45